Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Rev Med Interne ; 19(9): 658-60, 1998 Sep.
Artigo em Francês | MEDLINE | ID: mdl-9793153

RESUMO

INTRODUCTION: Endogenous endophthtalmitis is an intraocular infection of hematogenous origin. EXEGESIS: It is generally a panuveitis that may be mixed-up with a non-infectious inflammatory disease, promoting delayed treatment and compromising the visual prognosis, as the visual loss rate reaches up to 37.5%. Antibiotherapy should be started immediately after bacteriological examinations and without waiting for vitrectomy. Identification of the causative microorganism is absolutely necessary. It may require aqueous or vitreous culture if cultures from other body fluids are negative and infection progresses. The most common infections are endocarditis and digestive and renal diseases. Virectomy is indicated for first line treatment of ocular abcess and improvement of antibiotic absorption. However, it may lead to retinal detachment. Vitrectomy is also indicated in case of unsuccessful therapy. To decrease the inflammatory reaction and risks of vitreous organization, local or systemic corticotherapy is prescribed after control of the infection. CONCLUSION: Although rare, endogenous endophthalmitis should be diagnosed as it may be mixed-up with inflammatory uveitis, leading to inappropriate corticotherapy. Furthermore, antibiotherapy with good intraocular penetration should be started immediately, but it should be kept in mind that the functional prognosis is poor.


Assuntos
Antifúngicos/uso terapêutico , Candidíase/tratamento farmacológico , Quimioterapia Combinada/uso terapêutico , Endoftalmite/tratamento farmacológico , Infecções Estafilocócicas/tratamento farmacológico , Idoso , Anfotericina B/uso terapêutico , Candidíase/complicações , Candidíase/diagnóstico , Endoftalmite/microbiologia , Endoftalmite/cirurgia , Flucitosina/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Ofloxacino/uso terapêutico , Oxacilina/uso terapêutico , Rifampina/uso terapêutico , Infecções Estafilocócicas/complicações , Infecções Estafilocócicas/diagnóstico , Vitrectomia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...